MVA congratulates member company, Scandion Oncology, with their IPO on Spotlight Stock Market and first day of trading


    Today was the first day of trading in Scandion Oncology A/S shares on Spotlight Stock Market. MVA would like to congratulate, CEO (and MVA Oncology Network co-founder), Nils Brünner, and, CSO, Jan Stenvang, with what appeared to be a joyful start of the day and a promising next step for the development of new cancer treatments that will overcome chemotherapy resistance.